{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T14:13:10Z","timestamp":1786975990776,"version":"build-2736575974"},"update-to":[{"DOI":"10.1002\/14651858.cd007245.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2020,12,21]],"date-time":"2020-12-21T00:00:00Z","timestamp":1608508800000}}],"reference-count":30,"publisher":"Wiley","issue":"2","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd007245.pub4","type":"journal-article","created":{"date-parts":[[2020,12,21]],"date-time":"2020-12-21T18:50:26Z","timestamp":1608576626000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen"],"prefix":"10.1002","volume":"2021","author":[{"given":"Sally AD","family":"Romero","sequence":"additional","affiliation":[{"name":"Family Medicine and Public Health; University of California, San Diego; La Jolla CA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie","family":"Young","sequence":"additional","affiliation":[{"name":"School of Medicine; University of California, San Diego; San Diego USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha","family":"Hickey","sequence":"additional","affiliation":[{"name":"The University of Melbourne; The Royal Women's Hospital; Melbourne Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H Irene","family":"Su","sequence":"additional","affiliation":[{"name":"Department of Reproductive Medicine; University of California, San Diego; La Jolla California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2020,12,21]]},"reference":[{"issue":"12","key":"10.1002\/14651858.CD007245.pub4-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"1510-5","DOI":"10.1111\/j.1471-0528.2007.01545.x","article-title":"A randomised controlled trial of prophylactic levonorgestrel intrauterine system in tamoxifen treated women","volume":"114","author":"Chan","year":"2007","journal-title":"BJOG"},{"issue":"5","key":"10.1002\/14651858.CD007245.pub4-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1097\/AOG.0b013e31828bf80c","article-title":"Prophylactic use of levonorgestrel-releasing intrauterine system in women with breast cancer treated with tamoxifen: a randomized controlled trial","volume":"121","author":"Wong","year":"2013","journal-title":"Obstetrics and Gynecology"},{"issue":"9243","key":"10.1002\/14651858.CD007245.pub4-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1016\/S0140-6736(00)03204-9","article-title":"Endometrial protection from tamoxifen-stimulated changes by a levonorgestrel-releasing intrauterine system: a randomised controlled trial","volume":"356","author":"Gardner","year":"2000","journal-title":"Lancet"},{"issue":"3","key":"10.1002\/14651858.CD007245.pub4-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.ygyno.2009.06.014","article-title":"Prevention of tamoxifen induced endometrial polyps using levonorgestrel releasing intrauterine system: long-term follow-up of a randomised control trial","volume":"114","author":"Gardner","year":"2009","journal-title":"Gynecologic Oncology"},{"issue":"3","key":"10.1002\/14651858.CD007245.pub4-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1080\/13697130802163168","article-title":"Long-term effects of the levonorgestrel-releasing intrauterine system on serum lipids and the endometrium in breast cancer patients taking tamoxifen","volume":"11","author":"Kesim","year":"2008","journal-title":"Climacteric"},{"issue":"1","key":"10.1002\/14651858.CD007245.pub4-BIB0006|cit6","first-page":"327","article-title":"The use of levonorgestrel-releasing intrauterine system in prevention of endometrial pathology in women with breast cancer treated with tamoxifen","volume":"3","author":"Omar","year":"2010","journal-title":"International Journal of Medicine"},{"issue":"6","key":"10.1002\/14651858.CD007245.pub4-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1097\/01.AOG.0000450757.18294.cf","article-title":"Tamoxifen and uterine cancer","volume":"123","author":"ACOG Committee Opinion No 601","year":"2014","journal-title":"Obstetrics and Gynecology"},{"issue":"5","key":"10.1002\/14651858.CD007245.pub4-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1097\/01.AOG.0000465189.50026.20","article-title":"Endometrial intraepithelial neoplasia","volume":"125","author":"ACOG Committee\u00a0 Opinion\u00a0 No\u00a0 631","year":"2015","journal-title":"Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD007245.pub4-BIB0009|cit9","unstructured":"American Cancer Society How common is breast cancer? www.cancer.org\/cancer\/breast-cancer\/about\/how-common-is-breast-cancer.html"},{"issue":"9869","key":"10.1002\/14651858.CD007245.pub4-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S0140-6736(12)61963-1","article-title":"Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial","volume":"381","author":"Davies","year":"2013","journal-title":"Lancet"},{"issue":"9793","key":"10.1002\/14651858.CD007245.pub4-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S0140-6736(11)60993-8","article-title":"Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials","volume":"378","author":"Davies","year":"2011","journal-title":"Lancet"},{"issue":"10001","key":"10.1002\/14651858.CD007245.pub4-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/S0140-6736(15)61074-1","article-title":"Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials","volume":"386","author":"Early Breast Cancer Trialists' Collaborative Group (EBCTCG)","year":"2015","journal-title":"Lancet"},{"issue":"18","key":"10.1002\/14651858.CD007245.pub4-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1093\/jnci\/90.18.1371","article-title":"Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study","volume":"90","author":"Fisher","year":"1998","journal-title":"Journal of the National Cancer Institute"},{"issue":"3","key":"10.1002\/14651858.CD007245.pub4-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.ygyno.2009.06.014","article-title":"Prevention of tamoxifen induced endometrial polyps using levonorgestrel releasing intrauterine system: long-term follow-up of a randomised control trial","volume":"114","author":"Gardner","year":"2009","journal-title":"Gynecologic Oncology"},{"issue":"4","key":"10.1002\/14651858.CD007245.pub4-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1177\/1933719113503408","article-title":"Levonorgestrel intrauterine system in adjuvant tamoxifen treatment: balance of breast risks and endometrial benefits - systematic review of literature","volume":"21","author":"Gizzo","year":"2014","journal-title":"Reproductive Science"},{"key":"10.1002\/14651858.CD007245.pub4-BIB0016|cit16","unstructured":"McMaster University (developed by Evidence Prime) GRADEpro GDT"},{"key":"10.1002\/14651858.CD007245.pub4-BIB0017|cit17","unstructured":"Higgins JP Green S Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"2","key":"10.1002\/14651858.CD007245.pub4-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/ijc.24738","article-title":"A cases control study on hormone therapy as a risk factor for breast cancer in Finland","volume":"126","author":"Lyytinen","journal-title":"International Journal of Cancer"},{"issue":"9","key":"10.1002\/14651858.CD007245.pub4-BIB0019|cit19","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012658.pub2","article-title":"Levonorgestrel-releasing intrauterine system for endometrial hyperplasia","author":"Mittermeier","year":"2020","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD007245.pub4-BIB0020|cit20","unstructured":"National Comprehensive Cancer Network Breast\u00a0Cancer (Version 6.2020) Available at www.nccn.org\/professionals\/physician_gls\/pdf\/breast.pdf"},{"issue":"8","key":"10.1002\/14651858.CD007245.pub4-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1080\/01443615.2019.1587600","article-title":"The levonorgestrel-releasing intrauterine device induces endometrial decidualisation in women on tamoxifen","volume":"39","author":"Philip","year":"2019","journal-title":"Journal of Obstetrics and Gynaecology"},{"issue":"1","key":"10.1002\/14651858.CD007245.pub4-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1102\/1470-7330.2008.0020","article-title":"The effect of tamoxifen on the genital tract","volume":"8","author":"Polin","year":"2008","journal-title":"Cancer Imaging"},{"key":"10.1002\/14651858.CD007245.pub4-BIB0023|cit23","unstructured":"Nordic Cochrane Centre, The Cochrane Collaboration Review Manager 5 (RevMan 5) 2014"},{"issue":"3","key":"10.1002\/14651858.CD007245.pub4-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0015-0282(16)37382-4","article-title":"Intrauterine administration of progesterone by a slow releasing device","volume":"21","author":"Scommegna","year":"1970","journal-title":"Fertility and Sterility"},{"issue":"1","key":"10.1002\/14651858.CD007245.pub4-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.fertnstert.2007.05.033","article-title":"Use of the levonorgestrel-releasing intrauterine system in breast cancer patients","volume":"90","author":"Trinh","year":"2008","journal-title":"Fertility and Sterility"},{"issue":"5","key":"10.1002\/14651858.CD007245.pub4-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1097\/AOG.0b013e31828bf80c","article-title":"Prophylactic use of levonorgestrel-releasing intrauterine system in women with breast cancer treated with tamoxifen: a randomized controlled trial","volume":"121","author":"Wong","year":"2013","journal-title":"Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD007245.pub4-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/0010-7824(90)90035-T","article-title":"Pharmacokinetic and pharmacodynamic studies of levonorgestrel-releasing intrauterine device","volume":"41(4)","author":"Xiao","year":"1990","journal-title":"Contraception"},{"issue":"3","key":"10.1002\/14651858.CD007245.pub4-BIB0028|cit28","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007245","article-title":"Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen","author":"Chin","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD007245.pub4-BIB0029|cit29","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007245.pub2","article-title":"Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen","author":"Chin","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"12","key":"10.1002\/14651858.CD007245.pub4-BIB0030|cit30","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007245.pub3","article-title":"Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen","author":"Dominick","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2021,9,21]],"date-time":"2021-09-21T03:06:48Z","timestamp":1632193608000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD007245.pub4"}},"subtitle":[],"editor":[{"name":"Cochrane Gynaecology and Fertility Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,12,21]]},"references-count":30,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,2]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd007245.pub4","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,21]]}}}